They found at least one plasma biomarker in 85.7% of CRC samples with prognostic and diagnostic significance but excluded SEPT9 from their analysis, since it failed to reach their stringent inclusion criteria. This evidence concerns the gene SEPTIN9 and colorectal carcinoma.